A detailed history of Quadrant Capital Group LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 469 shares of AVNS stock, worth $7,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
469
Previous 518 9.46%
Holding current value
$7,513
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$19.21 - $24.69 $941 - $1,209
-49 Reduced 9.46%
469 $11,000
Q2 2024

Aug 12, 2024

BUY
$17.85 - $20.42 $8,514 - $9,740
477 Added 1163.41%
518 $10,000
Q1 2024

May 15, 2024

SELL
$17.97 - $22.68 $2,947 - $3,719
-164 Reduced 80.0%
41 $0
Q4 2023

Feb 08, 2024

SELL
$17.64 - $22.99 $10,354 - $13,495
-587 Reduced 74.12%
205 $4,000
Q3 2023

Nov 14, 2023

BUY
$19.93 - $26.31 $4,922 - $6,498
247 Added 45.32%
792 $16,000
Q2 2023

Aug 09, 2023

SELL
$22.53 - $30.98 $9,980 - $13,724
-443 Reduced 44.84%
545 $13,000
Q4 2022

Feb 10, 2023

BUY
$19.88 - $27.37 $6,262 - $8,621
315 Added 46.81%
988 $26,000
Q3 2022

Nov 10, 2022

BUY
$21.56 - $29.59 $13,367 - $18,345
620 Added 1169.81%
673 $15,000
Q2 2022

Aug 09, 2022

SELL
$24.87 - $34.68 $298 - $416
-12 Reduced 18.46%
53 $1,000
Q4 2021

Feb 01, 2022

BUY
$29.25 - $36.02 $351 - $432
12 Added 22.64%
65 $2,000
Q2 2020

Aug 13, 2020

SELL
$23.48 - $33.86 $50,505 - $72,832
-2,151 Reduced 97.6%
53 $2,000
Q1 2020

May 15, 2020

BUY
$20.64 - $34.41 $15,170 - $25,291
735 Added 50.03%
2,204 $58,000
Q4 2019

Feb 03, 2020

BUY
$31.89 - $47.34 $159 - $236
5 Added 0.34%
1,469 $48,000
Q1 2019

Apr 29, 2019

SELL
$39.84 - $51.04 $199 - $255
-5 Reduced 0.34%
1,464 $61,000
Q2 2018

Aug 09, 2018

BUY
$44.94 - $60.96 $66,016 - $89,550
1,469 New
1,469 $82,000

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $745M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.